Fox Run Management, L.L.C. Qiagen N.V. Transaction History

Fox Run Management, L.L.C.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$35.55 - $43.57 $308,111 - $377,621	8,667 New	8,667 $376,000
Q2 2023 Aug 11, 2023	SELL	$43.93 - $46.76 $545,171 - $580,291	-12,410 Reduced 60.65%	8,053 $362,000
Q1 2023 May 12, 2023	BUY	$45.29 - $50.76 $926,769 - $1.04 Million	20,463 New	20,463 $939,000
Q3 2022 Nov 07, 2022	BUY	$40.9 - $50.42 $358,611 - $442,082	8,768 New	8,768 $362,000
Q2 2019 Jul 17, 2019	BUY	$35.73 - $41.39 $312,458 - $361,955	8,745 New	8,745 $355,000
Q4 2018 Jan 15, 2019	SELL	$32.65 - $37.95 $755,880 - $878,580	-23,151 Closed	0 $0
Q3 2018 Oct 05, 2018	BUY	$35.99 - $39.39 $598,261 - $654,779	16,623 Added 254.64%	23,151 $877,000
Q2 2018 Jul 17, 2018	SELL	$31.23 - $37.47 $212,207 - $254,608	-6,795 Reduced 51.0%	6,528 $236,000
Q1 2018 Apr 17, 2018	BUY	$31.01 - $34.72 $413,146 - $462,574	13,323 New	13,323 $430,000
Q4 2017 Jan 18, 2018	SELL	$30.68 - $35.37 $733,252 - $845,342	-23,900 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$31.02 - $32.94 $741,378 - $787,266	23,900	23,900 $753,000

6.34M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.2B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.